EU’s Largest Private Biotech talking on the Future of mRNA Therapies

12/11/2015 - 1 minute

Today is the 3rd International mRNA Health Conference in Berlin. I jumped in the metro to go there and interview the most successful people of the field…

biontech-rna_webWe first interviewed Sean Marett, COO of BioNTech. This German Biotech is the largest private Biotech in EU and so far counts over 400 employees…BioNTech also  recently signed a huge €1.37 billion deal with Sanofi on 5 mRNA therapies program.

Today’s conference was a great opportunity to discuss this deal and to hear Sean’s vision on the future of the Biotech mRNA field.

Founded only 4 years ago, this German biotech is certainly going places then. Last year they opened a massive 10,000 square metre research centre with Ganymed, also located on the Johannes-Gutenberg campus, as well as recently signing a deal with Tech Giant Siemens for another new production plant.

Biontech_mrna_conference_berlin

 

Here’s the interview with Sean…Please accept preferences cookies to watch this video.

This content is available exclusively to our paying members.

Our members receive the following benefits:

  • Unlock premium articles
  • Download our industry reports
  • Remove all banner ads
  • Access 1,500+ archived posts
  • Support our independent media
Already a member? Sign in
ADVERTISEMENT
Do you want to remove this advert? Become a member!
ADVERTISEMENT
Do you want to remove this advert? Become a member!

Support Us

Become a Member